Method Article

Procedures for the Identification of SARS-CoV-2 Entry Inhibitors as Potential Antivirals using MLV-Based Pseudoviruses

DOI:

10.3791/69628

February 27th, 2026

In This Article

Summary

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This article describes the methodology for generating SARS-CoV-2 pseudotyped particles using a luciferase reporter system and its use to identify entry inhibitors. These protocols are demonstrated using two different entry-inhibitors, a recombinant human ACE2-Fc fusion protein and the small-molecule compound arbidol.

Abstract

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The SARS-CoV-2 virus is an emergent, zoonotic pathogen that has caused a huge burden of disease and mortality around the world since its emergence in 2019. Safe and accessible platforms to evaluate viral entry and potential antiviral compounds remain essential for ongoing drug discovery against emerging variants. This article describes a highly optimized protocol for generating murine leukemia virus (MLV)-based pseudotyped particles expressing the SARS-CoV-2 spike protein and carrying a luciferase reporter gene, enabling the study of viral entry under biosafety level 2 conditions. The methods described detail the use of optimized cell lines, high transfection efficiency using cost-effective reagents, production of highly effective pseudoviruses, and titration of infectivity to determine the minimum viral input for screening assays. Representative results demonstrate robust luciferase activity in infected cells compared to non-infected controls, while control spike-less and VSV-G-pseudoviruses confirm assay specificity. Furthermore, the system supports compound screening by quantifying inhibitory effects on viral entry and assessing cytotoxicity using an MTT viability assay. Overall, this reproducible and scalable protocol provides a reliable platform for medium to high-throughput screening of novel viral entry inhibitors, contributing to the identification of antiviral candidates and advancing research on SARS-CoV-2 entry mechanisms.

Introduction

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) during late 2019 led to a global pandemic that resulted in millions of deaths worldwide and continues to pose a threat through new variants with increased transmissibility and immune escape potential1. As an enveloped RNA virus from the Coronaviridae family, SARS-CoV-2 utilizes its trimeric spike (S) glycoprotein to mediate host cell entry by binding to the angiotensin-converting enzyme 2 (ACE2) receptor and undergoing proteolytic activation by TMPRSS2 and other host proteases2,3. While several treatment optio....

Access restricted. Please log in or start a trial to view this content.

Protocol

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

1. High efficiency transfection of HEK293T-derived cells using branched polyethyleneimine (PEI)

NOTE: Perform all steps in a biosafety cabinet using standard aseptic technique and BSL-2 procedures. Use HEK293T-derived cells for transfection and generation of pseudotyped viruses. In this Method cells are transfected in cell culture-treated 6 well plates. The PEI stock solution is prepared as previously described by Yang and colleagues (2017)12. Before proceeding to do the triple transfection to generate the pseudovirus, it is advisable to optimize the best PEI-plasmid DNA proportion to ensure a high tra....

Access restricted. Please log in or start a trial to view this content.

Results

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Several transfection methods have been reported to generate PVs, including calcium phosphate15, lipid-based methods16, and PEI, both linear and branched. This article shows that transfection of HEK293T-derived cells with branched PEI allows for high-efficiency transfection (Figure 1), usually comparable to transfection methods using commercially available lipid-based transfection agents (data not shown). Representative results corresponding to .......

Access restricted. Please log in or start a trial to view this content.

Discussion

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This versatility of the MLV system for generating pseudotypes for other viruses has been reported by other important viruses, such as Ebola virus18, MERS-CoV8, SARS-CoV19, La Crosse virus20, Hantavirus20, Visna virus21, Arenavirus22, Influenza virus23, and others. These pseudotypes have been very useful for an array of applications .......

Access restricted. Please log in or start a trial to view this content.

Disclosures

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The authors have nothing to disclose.

Acknowledgements

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

We thank the Sistema Nacional de Investigación (SNI) and the Secretaría Nacional de Ciencia, Tecnología e Innovación (SENACYT, Panamá) for financial support under contract SENACYT No.031-2022 and SNI contract No.050-2023. We are also very grateful to Dr. Gary Whittaker for the donation of the plasmids pCMV-MLVgagpol and pTG-Luc.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
0.2 µm Low protein-binding syringe filters Thermo Scientific720-1320Syringe Filters (0.2 μm,13 mm, PES, sterile)
0.25% Trypsin-EDTA 1X solutionGibco25200-056Trypsin-EDTA (0.25%), phenol red
0.45 µm PVDF Bottle-Top Filter Units Avantor514-1045Bottle-Top Vacuum Filtration Systems (PVDF, 250 ml, 50 mm, 0,45 µm)
1.5 mL Sterile Microcentrifuge TubesEppendorf30123611Safe-Lock Tubes
100 X Penicillin Streptomycin solutionCorning30-002-CIPenicillin-Streptomycin Solution, 100x
5 X Luciferase assay lysis buffer PromegaE2650part of the Promega Bright-Glo Luciferase Assay System
50 mL Sterile Conical TubesCorning 35207050 mL High Clarity PP Centrifuge Tube, Conical Bottom, Sterile
6-well Tissue Culture PlatesThermo Scientific140675Cell-Culture Treated Multidishes
96-well Tissue Culture PlatesThermo Scientific168055Nunc™ MicroWell™ 96-Well, Nunclon Delta-Treated, Flat-Bottom Microplate
Arbidol hydrochlorideSigma-AldrichSML0860
Branched polyethylenimine, 25 kDaSigma-Aldrich408727
Confocal laser microscope (FV 3000)Olympus Co.SKU: FV3000
Dimethyl sulfoxide (DMSO)Sigma-AldrichD8418
DMEM (Dulbecco's Modified Eagle Medium) With: High Glucose, L-glutamine, Phenol Red, Sodium Pyruvate)Gibco11995-065
Fetal Bovine Serum (FBS)Gibco26140-079Heat-inactivated (56°C, 30 min)
HEK293T-derived cells (Lenti-X 293T Cell Line)Takara Bio632180Highly transfectable subclone of HEK293 cell line and supports high levels of viral protein expression
HEPES BufferGibco15630-080
Highly susceptible cells for infection (293T-ACE2.TMPRSS2 (mCherry) Cell Line)BEI ResourcesNR-55293HEK293T cell line modified to stably express ACE2 and TMPRSS2
Hydrochloric acid Sigma-AldrichH1758-500ML
Inverted phase contrast microscope Olympus Co. SKU: 2404040005
IsopropanolSigma-AldrichI9516-500ML
Luciferase substratePromegaE2650part of the Bright-Glo Luciferase Assay System
Microplate reader with luminescence detectionAgilent BioTekBTH1MG
MTT [3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide]Sigma-AldrichM2128
Opaque White 96-well PlatesCorning391796-well Solid White Flat Bottom Polystyrene TC-treated Microplates
ParafilmBemisPM999
pcDNA3-EGFP plasmidAddgene13031pcDNA3-EGFP was a gift from Doug Golenbock (Addgene plasmid # 13031 ; http://n2t.net/addgene:13031 ; RRID:Addgene_13031)
pCMV-MLVgagpol plasmid--Kindly donated by Dr. Gary Whittaker 
Phosphate-buffered saline without Ca2+ and Mg2+ (PBS)Corning21-040-CVPhosphate-Buffered Saline, 1X without calcium and magnesium
Promega PureYield Plasmid Maxiprep SystemPromegaA2393
pTG-Luc plasmid--Kindly donated by Dr. Gary Whittaker 
pUNO1-SARS-CoV-2 Spike (Wuhan) plasmidInvivogenp1-spike
pVSV-G plasmidAddgene138479pVSV-G was a gift from Akitsu Hotta (Addgene plasmid # 138479 ; http://n2t.net/addgene:138479 ; RRID:Addgene_138479)
Recombinant Human ACE2-Fc fusion proteinInvivogenfc-hace2
Reduced serum medium (Opti-MEM)Gibco31985-070Opti-MEM Reduced Serum Medium

References

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,
  1. Li, J., et al. SARS-CoV-2 and emerging variants: Unmasking structure, function, infection, and immune escape mechanisms. Front Cell Infect Microbiol. 12, 869832(2022).
  2. Jackson, C. B., Farzan, M., Chen, B., Choe, H. Mechanisms of SA....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

Pseudovirus AssayAntiviral ScreeningMLV PseudovirusesSpike ProteinLuciferase ReporterHigh Throughput ScreeningCell TransfectionViral Entry Mechanisms

Related Articles